In a hypotensive, oliguric, volume‑depleted child with acute kidney injury, should steroids be initiated?

Steroids Should NOT Be Routinely Initiated in This Clinical Scenario

In a hypotensive, oliguric, volume-depleted child with acute kidney injury, steroids are NOT indicated as initial therapy—aggressive fluid resuscitation and hemodynamic support take absolute priority, with hydrocortisone reserved only for specific high-risk conditions of adrenal insufficiency that persist despite catecholamine support.

Initial Management Priority: Volume Resuscitation

The cornerstone of management for a hypotensive, oliguric, volume-depleted child with AKI is immediate aggressive fluid resuscitation, not steroids 1:

• Administer rapid fluid boluses of 20 mL/kg (isotonic crystalloid or 5% albumin) by push or rapid infusion device 1
• Repeated boluses can be given up to 200 mL/kg in the first hour if no signs of fluid overload develop (increased work of breathing, rales, gallop rhythm, hepatomegaly) 1
• Children commonly require 40-60 mL/kg in the first hour for adequate resuscitation 1
• Correct hypoglycemia and hypocalcemia immediately 1

Volume depletion is a common and modifiable risk factor for AKI in children, and prompt fluid administration is paramount 2.

Hemodynamic Support: Vasopressors Before Steroids

If the child remains hypotensive despite adequate fluid resuscitation (fluid-refractory shock), the next step is vasopressor/inotropic support, not steroids 1:

• Begin peripheral inotrope (low-dose dopamine or epinephrine) if a second peripheral IV/intraosseous catheter is available while establishing central access 1
• Central dopamine may be titrated through central venous access 1
• For fluid-refractory/dopamine-resistant shock: Start central epinephrine for cold shock (0.05-0.3 μg/kg/min) or norepinephrine for warm shock 1

When Steroids ARE Indicated: Very Specific Circumstances Only

Hydrocortisone should be considered ONLY if the child meets ALL of the following criteria 1:

1. At risk for absolute adrenal insufficiency or adrenal-pituitary axis failure, specifically:

   • Purpura fulminans
   • Congenital adrenal hyperplasia
   • Prior recent steroid exposure
   • Hypothalamic/pituitary abnormality 1

2. AND remains in shock DESPITE epinephrine or norepinephrine infusion 1

Hydrocortisone Dosing When Indicated

If the above criteria are met 1:

• Obtain blood sample for baseline cortisol before administration (ideally) 1
• Dosage range: 1-2 mg/kg/day for stress coverage up to 50 mg/kg/day titrated to reversal of shock 1
• May be given as intermittent or continuous infusion 1

Important caveat: Patients with vasopressor-resistant hypotension attributed to adrenal insufficiency might respond to stress-dose hydrocortisone only, thus avoiding high doses of other lymphocytotoxic corticosteroids (dexamethasone or methylprednisolone) 1.

Critical Pitfalls to Avoid

Do NOT Use Steroids for AKI Itself

• Steroids have NO role in treating AKI from volume depletion, acute tubular necrosis, or interstitial nephritis in this context 3, 4
• The only exception is drug-induced interstitial nephritis with documented biopsy findings, which is NOT the scenario described here 5

Do NOT Delay Fluid Resuscitation

• Oliguria may represent appropriate physiologic response to volume depletion rather than established kidney injury 1
• Early aggressive fluid resuscitation can prevent progression to established AKI 2, 6
• Both under-resuscitation and fluid overload are harmful—monitor carefully for signs of volume overload 1

Do NOT Confuse Nephrotic Syndrome Management with AKI Management

• The evidence provided includes extensive guidelines on steroid use for nephrotic syndrome 1, which is fundamentally different from managing AKI with hypovolemia
• In nephrotic syndrome, steroids treat the underlying glomerular disease
• In hypovolemic AKI, steroids do NOT address the primary pathophysiology and may cause harm through immunosuppression and metabolic complications

Monitoring and Therapeutic Goals

Once fluid resuscitation and hemodynamic support are initiated 1:

Target endpoints:

• Capillary refill ≤2 seconds
• Normal perfusion pressure (MAP - central venous pressure) for age
• Urine output >1 mL/kg/h
• ScvO2 >70%
• Cardiac index 3.3-6.0 L/min/m²

Essential monitoring:

• Continuous vital signs and intra-arterial blood pressure
• Urine output (hourly)
• Central venous pressure/oxygen saturation
• Glucose, calcium, lactate, INR, anion gap 1